| Corticoid Therapy in Acute Myocarditis (NCT06522100) | Assistance Publique - Hôpitaux de Paris | 2025-02-01 |
| Comparative Evaluation of Giomer Varnish vs Fluoride Varnish as Desensitizing Agents in Teeth With MIH (NCT05542667) | Cairo University | 2025-02-01 |
| Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis (NCT06818279) | Institute of Liver and Biliary Sciences, India | 2025-01-31 |
| ORal Antibiotics in Acute Mesenteric Ischemia (NCT06387147) | Assistance Publique - Hôpitaux de Paris | 2025-01-31 |
| Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients (NCT06747130) | Phramongkutklao College of Medicine and Hospital | 2025-01-31 |
| REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial (NCT06650579) | Emory University | 2025-01-31 |
| A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) (NCT06799000) | Novartis Pharmaceuticals | 2025-01-31 |
| A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan (NCT06741683) | Takeda | 2025-01-31 |
| FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan (NCT07356388) | kewen Chen,MD | 2025-01-30 |
| Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease (NCT06347536) | Guy's and St Thomas' NHS Foundation Trust | 2025-01-30 |
| Actual Use Trial of Tadalafil 5 mg (NCT06805513) | Sanofi | 2025-01-30 |
| Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC (NCT06768255) | Ding-Wei Ye | 2025-01-30 |
| A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer (NCT06939595) | Celltrion | 2025-01-30 |
| Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy (NCT06724237) | Eastern Cooperative Oncology Group | 2025-01-30 |
| Short Benznidazole Regimen for Chronic Phase Chagas Disease Patients (NCT06339710) | Evandro Chagas Institute of Clinical Research | 2025-01-30 |
| A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) (NCT06809595) | Definium Therapeutics US, Inc. | 2025-01-29 |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC (NCT06788990) | Bicara Therapeutics | 2025-01-28 |
| Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula (NCT05843877) | Technische Universität Dresden | 2025-01-28 |
| Tissue Repair Gel in Venous Leg Ulcers (US) (NCT06707090) | TR Therapeutics | 2025-01-28 |
| The Effect of Oral Administration of Hesperidin and Diosmin in Reducing Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients (NCT06811220) | Alexandria University | 2025-01-27 |
| Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis (NCT06863701) | Laboratorios Silanes S.A. de C.V. | 2025-01-27 |
| A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia (NCT06767683) | Alkermes, Inc. | 2025-01-27 |
| Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage (NCT05245227) | Stony Brook University | 2025-01-27 |
| Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH (NCT05140525) | Dr Sudarshan Rajagopal | 2025-01-27 |
| The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction (NCT07381803) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-01-27 |
| DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection (NCT06203132) | ANRS, Emerging Infectious Diseases | 2025-01-27 |
| A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) (NCT06717347) | Merck Sharp & Dohme LLC | 2025-01-27 |
| Intravenous Thrombolysis and NOAC (NCT06749834) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-01-27 |
| PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study (NCT06713616) | Yale University | 2025-01-27 |
| Aesthetic Restorations in Deciduous Anterior Teeth (NCT05875064) | University of Nove de Julho | 2025-01-26 |
| Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease (NCT06797011) | Institute of Liver and Biliary Sciences, India | 2025-01-25 |
| A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients (NCT06771245) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2025-01-24 |
| A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo (NCT06548360) | Incyte Corporation | 2025-01-24 |
| A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (NCT06767540) | Akeso | 2025-01-23 |
| A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease (NCT06100289) | Takeda | 2025-01-22 |
| A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies (NCT06698796) | Pfizer | 2025-01-22 |
| A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants (NCT06794866) | AbbVie | 2025-01-22 |
| Testing the Efficacy of Safe South Africa (NCT06750107) | Brown University | 2025-01-22 |
| Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) (NCT06786624) | Neurocrine Biosciences | 2025-01-22 |
| Automated Insulin Delivery for Inpatients With Dysglycemia (NCT06418880) | Emory University | 2025-01-22 |
| Candin for the Treatment of Common Warts (NCT05889845) | Nielsen BioSciences, Inc. | 2025-01-22 |
| Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). (NCT06641414) | Ascentage Pharma Group Inc. | 2025-01-22 |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease (NCT06585774) | Incyte Corporation | 2025-01-21 |
| MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children (NCT05541276) | Arash Afshari | 2025-01-21 |
| Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas (NCT06872541) | University of Sao Paulo | 2025-01-20 |
| Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension (NCT06682000) | Daewoong Pharmaceutical Co. LTD. | 2025-01-20 |
| Dapagliflozin in STEMI (NCT06174753) | Ottawa Heart Institute Research Corporation | 2025-01-20 |
| Electronic Harm Reduction Treatment for Alcohol (NCT06702007) | University of Washington | 2025-01-20 |
| DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases (NCT06555003) | Tehran University of Medical Sciences | 2025-01-20 |
| Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception (NCT06727734) | The University of Hong Kong | 2025-01-18 |
| mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC (NCT06791512) | Jun Huang | 2025-01-18 |
| Optimizing HFrEF Patients Using BaroStim and CardioMems (NCT07399587) | Northwell Health | 2025-01-17 |
| Surgery with Botulinum Toxin a for Incisional Hernia (NCT06499324) | Assistance Publique - Hôpitaux de Paris | 2025-01-17 |
| External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia (NCT06404775) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-01-16 |
| Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible (NCT06055257) | Sunnybrook Health Sciences Centre | 2025-01-16 |
| Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD (NCT06724809) | Alexion Pharmaceuticals, Inc. | 2025-01-16 |
| Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS (NCT05814432) | Federal University of Health Science of Porto Alegre | 2025-01-16 |
| A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise (NCT06777238) | Gan & Lee Pharmaceuticals. | 2025-01-16 |
| A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) (NCT06730061) | Ipsen | 2025-01-16 |
| A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome (NCT06684847) | argenx | 2025-01-15 |
| HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) (NCT06634420) | Intellia Therapeutics | 2025-01-15 |
| A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes (NCT06660290) | Alcon Research | 2025-01-15 |
| Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment (NCT06760065) | Sixth Affiliated Hospital, Sun Yat-sen University | 2025-01-15 |
| Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature (NCT05314998) | John Neoptolemos | 2025-01-15 |
| JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer (NCT06751485) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2025-01-15 |
| 21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia (NCT06613997) | Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 2025-01-15 |
| A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. (NCT06284317) | ETOP IBCSG Partners Foundation | 2025-01-15 |
| A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC (NCT06754644) | Qilu Pharmaceutical Co., Ltd. | 2025-01-15 |
| Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss (NCT06501924) | Applied Biology, Inc. | 2025-01-15 |
| Shortened Regimen for Drug-susceptible TB in Children (NCT06253715) | Johns Hopkins University | 2025-01-15 |
| SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma (NCT06743126) | Immatics US, Inc. | 2025-01-14 |
| REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis (NCT06788535) | Sharmila Dorbala | 2025-01-14 |
| Newborn Jaundice - An Investigation of Different Approaches to Light Therapy (NCT06702241) | Regionshospital Nordjylland | 2025-01-14 |
| Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential (NCT06672016) | Mylan Pharmaceuticals Inc | 2025-01-13 |
| Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) (NCT04867317) | VA Office of Research and Development | 2025-01-13 |
| Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) (NCT06700343) | Amgen | 2025-01-13 |
| Comparative Analysis Of Dexmedetomidine And Dexamethasone As An Adjuvant To 0.5%Ropivacaine On Onset Of Ultrasound Guided Supraclavicular Brachial Plexus Block In Patients Undergoing Upper Limb Surgeries (NCT07290595) | Sahiwal medical college sahiwal | 2025-01-13 |
| Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy (NCT06850454) | Mahidol University | 2025-01-10 |
| Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache (NCT06839118) | Danish Headache Center | 2025-01-10 |
| A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) (NCT06739122) | Eli Lilly and Company | 2025-01-10 |
| A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer (NCT07673029) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2025-01-10 |
| A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia (NCT06609226) | Novo Nordisk A/S | 2025-01-10 |
| SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy (NCT06946420) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2025-01-10 |
| Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1 (NCT06744504) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-10 |
| A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age (NCT06740630) | GlaxoSmithKline | 2025-01-10 |
| Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products (NCT06738485) | CSL Behring | 2025-01-09 |
| A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis (NCT06807424) | Janssen Research & Development, LLC | 2025-01-09 |
| Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy (NCT06711523) | Kexing Biopharm Co., Ltd. | 2025-01-09 |
| Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy (NCT06128980) | Herlev and Gentofte Hospital | 2025-01-09 |
| Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients (NCT05410275) | University Hospital, Tours | 2025-01-08 |
| Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis. (NCT06779071) | PharmaResearch Co.,Ltd | 2025-01-08 |
| Evaluation of the Efficacy of Oral Immunotherapy With Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study (NCT06771791) | University Hospital, Strasbourg, France | 2025-01-08 |
| Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis (NCT06549231) | University Hospital, Tours | 2025-01-08 |
| Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis (NCT06846541) | Alumis Inc | 2025-01-08 |
| Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing (NCT07267975) | University of Child Health Sciences and Children's Hospital, Lahore | 2025-01-07 |
| A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain (NCT06764186) | AstraZeneca | 2025-01-07 |
| Clonidine in Ultrasound-guided Rectus Sheath Block for Outpatient Umbilical Hernioplasty (NCT07062497) | Universidade Federal do Rio de Janeiro | 2025-01-07 |
| Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment (NCT06715943) | Chengdu Suncadia Medicine Co., Ltd. | 2025-01-07 |
| Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL (NCT06470451) | Soligenix | 2025-01-07 |
| Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (NCT06712316) | BioNTech SE | 2025-01-07 |